Keyword: Bayer

Though the top prize eluded the field, 10 pharma companies racked up gold, silver or bronze Lions for their marketing and advertising efforts.

Pharma entries for Cannes Lions Health honors are at a record low, but a bigger-than-ever group of drugmakers made the short list.

Blockbusters Humira and Keytruda will lead 2024 sales, according to an EvaluatePharma report, joined by new Sanofi launch Dupixent.

Bayer is taking a giant colon on tour. Yes, you read that right.

Regeneron needs some Type A newcomers to backstop its aging blockbuster Eylea, but so far, its trio of launches are still seeking traction.

A strong euro doesn't explain away Bayer's consumer health stall—or the low turnout for key cancer meds Xofigo and Stivarga.

Researchers scoured the database where pharma companies disclose payments made to physicians and discovered a troubling trend.

After Lilly’s Cyramza flopped a liver cancer trial in 2014, the company designed a trial for a specific subpopulation. Now, it’s back with a win.